Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07567131 · ClinicalTrials.gov registry record
Observational Study of Adults and Adolescents With Erythropoietic Protoporphyria (EPP) and X-linked Porphyria (XLP)
A clinical trial, sponsored by Portal Therapeutics.
- Recruiting
- Registry status
- 50
- Enrollment target
NCT07567131 is a clinical trial that is actively recruiting participants, run by Portal Therapeutics. The registered enrollment target is 50 participants.
The verdict
NCT07567131 is actively recruiting participants, sponsored by Portal Therapeutics.
- RECRUITING
- Registry status
- 50 participants
- Enrollment target
Study Summary
The purpose of this study is to collect information about the effects of EPP/XLP in adults and adolescents. This is an observational study in which participants will not receive any treatment. Study details include: * The study duration will be up to 6 months for each participant. * After Screening, participants will have a Baseline (Day 1) visit and return for visits every 4 weeks through 24 weeks. * Assessments to evaluate EPP/XLP will include clinical laboratory tests, physical exams, vital signs measurement, blood draws for PPIX concentration, reporting of EPP/XLP-related symptoms (including completion of a daily diary), light dosimetry.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2026-04-30 |
| Est. Completion | 2027-04-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07567131
The ClinicalTrials.gov registry entry for NCT07567131 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Portal Therapeutics, which has 2 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT07567131 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07567131 about?
NCT07567131 is a clinical study titled "Observational Study of Adults and Adolescents With Erythropoietic Protoporphyria (EPP) and X-linked Porphyria (XLP)". The purpose of this study is to collect information about the effects of EPP/XLP in adults and adolescents. This is an observational study in which participants will not receive any treatment. Study details include: * The study duration will be up to 6 months for each participant. * After Screening...
What is the current status of trial NCT07567131?
This trial is currently recruiting. The enrollment target is 50 participants. The study started on 2026-04-30. Estimated completion is 2027-04-01.
Who is sponsoring clinical trial NCT07567131?
This trial is sponsored by Portal Therapeutics, which has 2 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.